Showing results (381-390 of 405) with videos related to
Sort By:
Pageof 41
Infection Control and Hospital Epidemiology|August 30, 2018
Nosocomial transmission of hepatitis C virus in a liver transplant center in Hong Kong: implication of reusable blood collection tube holder as the vehicle for transmissionVincent C C Cheng, Shuk-Ching Wong, Sally C Y Wong, et al.The New England Journal of Medicine|October 9, 2009
MicroRNA expression, survival, and response to interferon in liver cancerJunfang Ji, Jiong Shi, Anuradha Budhu, et al.Journal of Hepatology|September 3, 2013
Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growthChang-Chun Ling, Kevin T P Ng, Yan Shao, et al.JAMA Network Open|June 10, 2024
Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer: A Nonrandomized Controlled TrialVictor Ho-Fun Lee, Varut Vardhanabhuti, Tiffany Cho-Lam Wong, et al.Journal of Hepatology|June 2, 2016
CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantationChang Xian Li, Chang Chun Ling, Yan Shao, et al.World Journal of Gastroenterology|May 30, 2013
High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patientsTan To Cheung, Sheung Tat Fan, See Ching Chan, et al.Oncotarget|November 22, 2017
A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinomaXiang Qi, Bing L Wong, Sze Hang Lau, et al.Cell Reports|October 18, 2018
PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF MethylationLok Hei Chan, Lei Zhou, Kai Yu Ng, et al.Nature Medicine|January 8, 2013
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinomaLeilei Chen, Yan Li, Chi Ho Lin, et al.Gut|November 30, 2022
Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patientsZhiwu Tan, Mei Sum Chiu, Xinxiang Yang, et al.Pageof 41